1. Assessing COVID-19-related symptoms in outpatient adult and adolescent subjects in clinical trials of drugs and biological products for COVID-19 prevention or treatment Publication: Silver Spring, MD : Center for Drug Evaluation and Research, September 2020 Subject(s): Clinical Trials as TopicCOVID-19 -- drug therapyCOVID-19 -- prevention & controlOutpatientsUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
